1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Farsad Eskandary: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Felzartamab in Late Antibody-Mediated Rejection Felzartamab, Placebo - Antibody-mediated Rejection | Phase 2 | Completed | Farsad Eskandary | 22 | 2021-10-06 | 2024-04-18 |
Saline Solution (1) · felzartamab (1)
Austria (1) · Germany (1)